Want to see CVSA full AI Analyst Report?
CVSA Stock Chart & Stats
$136.38
$3.59(3.10%)
At close: 4:00 PM EDT
$136.38
$3.59(3.10%)
Day’s Range― - ―
52-Week Range$86.97 - $156.26
Previous CloseN/A
Volume76.09K
Average Volume (3M)352.88K
Market Cap
$4.26B
Enterprise Value$4.82K
Total Cash (Recent Filing)$406.32M
Total Debt (Recent Filing)$905.50M
Price to Earnings (P/E)16.7
Beta0.66
Next Earnings
Oct 29, 2026EPS Estimate
1.83Next Dividend Ex-DateN/A
Dividend Yield1.21%
Share Statistics
EPS (TTM)7.55
Shares Outstanding34,038,820
10 Day Avg. Volume356,320
30 Day Avg. Volume352,883
Financial Highlights & Ratios
PEG Ratio1.20
Price to Book (P/B)3.02
Price to Sales (P/S)2.24
P/FCF Ratio11.12
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$159.50Price Target Upside16.95% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)8.89
Revenue Forecast (FY)$2.07B
Bulls Say, Bears Say
Bulls Say
Strong Profitability And Scale BenefitsCVSA’s strong gross, EBIT, and EBITDA margins indicate meaningful operating scale and a profitable services model. Sustained margin capacity can support reinvestment, resilience, and earnings growth while reinforcing the company’s ability to compete over the next several quarters.
Positive Revenue And EPS GrowthPositive revenue growth, alongside faster EPS growth, shows that CVSA is expanding its business while converting growth into shareholder earnings. If maintained, this pattern can strengthen operating leverage, support internal investment, and improve the durability of future profit generation.
Improving Free Cash FlowSubstantial and improving free cash flow gives CVSA greater capacity to fund operations, investment, and capital allocation without relying entirely on external financing. This cash generation also provides a durable buffer that can support strategic flexibility through normal business fluctuations.
Bears Say
Margin Volatility And Recent Net-margin PressureHistorical margin volatility, including the 2022 loss, shows that profitability has not been consistently stable across periods. The recent net-margin step-down may constrain earnings growth and indicates that costs or reinvestment demands could continue to pressure returns even as revenue expands.
Rising Absolute DebtAlthough leverage remains moderate, rising absolute debt reduces financial flexibility if profitability weakens or investment needs increase. Higher obligations can also limit future capital allocation choices and make maintaining balance-sheet resilience more dependent on continued operating performance.
Imperfect Operating Cash ConversionOperating cash flow converting at only about 70% of net income suggests that reported earnings are not translating fully into cash in the latest period. Together with weak or negative free cash flow in 2022, this points to potential cash-generation variability that could affect funding flexibility.
Covista News
CVSA FAQ
What was Covista’s price range in the past 12 months?
Covista lowest stock price was $86.97 and its highest was $156.26 in the past 12 months.
What is Covista’s market cap?
Covista’s market cap is $4.26B.
When is Covista’s upcoming earnings report date?
Covista’s upcoming earnings report date is Oct 29, 2026 which is in 49 days.
How were Covista’s earnings last quarter?
Covista released its earnings results on Aug 06, 2026. The company reported $2.09 earnings per share for the quarter, beating the consensus estimate of $1.892 by $0.198.
Is Covista overvalued?
According to Wall Street analysts Covista’s price is currently Undervalued.
Does Covista pay dividends?
Covista pays a Semiannually dividend of $0.18 which represents an annual dividend yield of 1.21%. See more information on Covista dividends here
What is Covista’s EPS estimate?
Covista’s EPS estimate is 1.83.
How many shares outstanding does Covista have?
Covista has 34,038,820 shares outstanding.
What happened to Covista’s price movement after its last earnings report?
Covista reported an EPS of $2.09 in its last earnings report, beating expectations of $1.892. Following the earnings report the stock price went up 13.456%.
Which hedge fund is a major shareholder of Covista?
Currently, no hedge funds are holding shares in CVSA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Covista Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$159.50 (16.95% Upside)
$159.50 (16.95% Upside)
Blogger Sentiment
Bullish
CVSA Sentiment 89%
Sector Average 61%
Sector Average 61%
Hedge Fund Trend
Decreased
By 271.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▼ 0.6%
Last 30 Days ▲ 1.2%
Last 30 Days ▲ 1.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-7.55%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
13.76%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Covista
Adtalem Global Education, Inc. is an enterprise dedicated to providing higher education. The company organizes its operations into three primary divisions: Chamberlain, Walden, and Medical and Veterinary. The Chamberlain segment delivers various degree and non-degree offerings within the nursing and broader health professions higher education sector. Through its Walden segment, the company offers extensive online learning options, including certificates, bachelor's, master's, and doctoral degrees in a wide range of subjects such as nursing, education, counseling, business, psychology, public health, social work, human services, public administration, public policy, and criminal justice. The Medical and Veterinary division provides both degree-granting and non-degree curricula tailored for post-secondary education in medicine and veterinary sciences. Dennis J. Keller and Ronald L. Taylor established the company in 1973, and its corporate headquarters are situated in Chicago, Illinois.
CVSA Company Deck
CVSA Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational and financial momentum: enrollment growth across institutions, improved margins (when adjusting for a one-week timing shift), raised revenue and EPS guidance, robust free cash flow, balance sheet improvement, share repurchases, campus expansion plans, and technology/AI initiatives. Near-term headwinds include an $18M timing impact at Walden that masked stronger underlying results, modest absolute enrollment improvement at Chamberlain this quarter (0.5%), continued investment-driven CapEx and strategic spending, and an expected higher effective tax rate. Overall, the positives (organic growth, margin expansion excluding timing, raised guidance, cash generation, and clear remediation at Chamberlain) outweigh the transitory and execution-related challenges noted.View all CVSA earnings summariesCVSA Stock 12 Month Forecast
Average Price Target
$159.50
▲(16.95% Upside)
Technical Analysis
Perdoceo Education
―
Grand Canyon Education
―
Strategic Education
―
Graham Holdings
―
Laureate Education
―
Ownership Overview
2.91% Insiders
40.56% Mutual Funds
21.28% Other Institutional Investors
6.85% Public Companies and
Individual Investors